PCSK1 mutations and human endocrinopathies: From obesity to gastrointestinal disorders

Endocrine Reviews

Volumn 37, Issue 4, 2016, Pages 347-371

  Stijnen, Pieter ^a   Ramos Molina, Bruno ^a   O'Rahilly, Stephen ^b   Creemers, John W M ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; CHOLECYSTOKININ; FATTY ACID; GASTROINTESTINAL HORMONE; GHRELIN; GLUCAGON LIKE PEPTIDE; INSULIN; MELANIN CONCENTRATING HORMONE; MONOSACCHARIDE; OREXIN A; OREXIN B; OXYTOCIN; PROINSULIN; PROPROTEIN CONVERTASE 1; TEDUGLUTIDE; PCSK1 PROTEIN, HUMAN;

ADRENAL FUNCTION; BODY MASS; CARBOXY TERMINAL SEQUENCE; CLINICAL FEATURE; CRYSTAL STRUCTURE; DIABETES INSIPIDUS; DIARRHEA; ENDOCRINE DISEASE; ENZYME ACTIVE SITE; ENZYME SPECIFICITY; GASTROINTESTINAL DISEASE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GROWTH HORMONE DEFICIENCY; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERPHAGIA; HYPOGONADOTROPIC HYPOGONADISM; HYPOTHYROIDISM; LOSS OF FUNCTION MUTATION; MALABSORPTION; MISSENSE MUTATION; MOUSE MODEL; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; RISK FACTOR; THYROID FUNCTION; UNFOLDED PROTEIN RESPONSE; ANIMAL; DEFICIENCY; GENETICS; METABOLISM;

ANIMALS; ENDOCRINE SYSTEM DISEASES; GASTROINTESTINAL DISEASES; HUMANS; OBESITY; PROPROTEIN CONVERTASE 1;

EID: 85008390886     PISSN: None     EISSN: 0163769X     Source Type: Journal    
DOI: 10.1210/er.2015-1117     Document Type: Review

References (218)

1. Seidah NG, Prat A. The biology and therapeutic targeting of the proprotein convertases. Nat Rev Drug Discov. 2012; 11(5):367-383
2. Seidah NG. The proprotein convertases, 20 years later. Methods Mol Biol. 2011;768:23-57
3. Hoshino A, Lindberg I. Peptide Biosynthesis: Prohormone Convertases 1/3 and 2 (Colloquium Series on Neuropeptides). San Rafael, CA: Morgan & Claypool Life Sciences; 2012:1-112
4. Seidah NG, Marcinkiewicz M, Benjannet S, et al. Cloning and primary sequence of a mouse candidate prohormone convertase PC1 homologous to PC2, furin, and Kex2: distinct chromosomal localization and messenger RNA distribution in brain and pituitary compared to PC2. Mol Endocrinol. 1991;5(1):111-122
5. Smeekens SP, Avruch AS, LaMendola J, Chan SJ, Steiner DF. Identification of a cDNA encoding a second putative prohormone convertase related to PC2 in AtT20 cells and islets of Langerhans. Proc Natl Acad Sci USA. 1991;88(2): 340-344
6. Seidah NG, Mattei MG, Gaspar L, Benjannet S, Mbikay M, ChretienM.Chromosomal assignments of the genes for neuroendocrine convertase PC1 (NEC1) to human 5q15-21, neuroendocrine convertase PC2 (NEC2) to human 20p11.1-11.2, and furin (mouse 7[D1-E2] region). Genomics. 1991;11(1):103-107
7. Seidah NG, Hamelin J, Gaspar AM, Day R, Chretien M. The cDNA sequence of the human pro-hormone and proprotein convertase PC1. DNA Cell Biol. 1992;11(4):283-289
8. Jansen E, AyoubiTA, MeulemansSM, VandeVenWJ.Cell type-specific protein-DNA interactions at the cAMP response elements of the prohormone convertase 1 promoter. Evidence for additional transactivators distinct from CREB/ATF family members. J Biol Chem. 1997;272(4): 2500-2508
9. Espinosa VP, Liu Y, Ferrini M, et al. Differential regulation of prohormone convertase 1/3, prohormone convertase 2 and phosphorylated cyclic-AMP-response element binding protein by short-term and long-term morphine treatment: implications for understanding the "switch" to opiate addiction. Neuroscience. 2008; 156(3):788-799
10. Zhou A, Martin S, Lipkind G, LaMendola J, Steiner DF. Regulatory roles of the P domain of the subtilisin-like prohormone convertases. J Biol Chem. 1998;273(18):11107-11114
11. Cameron A, Apletalina EV, Lindberg I. The enzymology of PC1 and PC2. In: Dalbey RE, Sigman DS, eds. The Enzymes. Vol 22, 3rd ed. Cambridge, MA: Academic Press; 2002:291-332
12. Zhou Y, Lindberg I. Purification and characterization of the prohormone convertase PC1(PC3). J Biol Chem. 1993; 268(8):5615-5623
13. Jean F, Basak A, Rondeau N, et al. Enzymic characterization of murine and human prohormone convertase-1 (mPC1 and hPC1) expressed in mammalian GH4C1 cells. Biochem J. 1993;292:891-900
14. Creemers JW, Roebroek AJ, Van de Ven WJ. Expression in human lung tumor cells of the proprotein processing enzyme PC1/PC3. Cloning and primary sequence of a 5 kb cDNA. FEBS Lett. 1992;300(1):82-88
15. Blanco EH, Peinado JR, Martín MG, Lindberg I. Biochemical and cell biological properties of the human prohormone convertase 1/3 Ser357Gly mutation: a PC1/3 hypermorph. Endocrinology. 2014;155(9):3434-3447
16. Zhu X, Lindberg I. 7B2 facilitates the maturation of proPC2 in neuroendocrine cells and is required for the expression of enzymatic activity. J Cell Biol. 1995;129(6): 1641-1650
17. Seidel B, Dong W, Savaria D, Zheng M, Pintar JE, Day R. Neuroendocrine protein 7B2 is essential for proteolytic conversion and activation of proprotein convertase 2 in vivo. DNA Cell Biol. 1998;17(12):1017-1029
18. Fricker LD, McKinzie AA, Sun J, et al. Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing. J Neurosci. 2000;20(2):639-648
19. Qian Y, Devi LA, Mzhavia N, Munzer S, Seidah NG, Fricker LD. The C-terminal region of proSAAS is a potent inhibitor of prohormone convertase 1. J Biol Chem. 2000; 275(31):23596-23601
20. Cameron A, Fortenberry Y, Lindberg I. The SAAS granin exhibits structural and functional homology to 7B2 and contains a highly potent hexapeptide inhibitor of PC1. FEBS Lett. 2000;473(2):135-138
21. Dong W, Seidel B, Marcinkiewicz M, Chretien M, Seidah NG, Day R. Cellular localization of the prohormone convertases in the hypothalamic paraventricular and supraoptic nuclei: selective regulation of PC1 in corticotrophinreleasing hormone parvocellular neurons mediated by glucocorticoids. J Neurosci. 1997;17(2):563-575
22. Billova S, Galanopoulou AS, Seidah NG, Qiu X, Kumar U. Immunohistochemical expression and colocalization of somatostatin, carboxypeptidase-E and prohormone convertases 1 and 2 in rat brain. Neuroscience. 2007; 147(2):403-418
23. Feng Y, Reznik SE, Fricker LD. Distribution of proSAASderived peptides in rat neuroendocrine tissues. Neuroscience. 2001;105(2):469-478
24. Schäfer MK, Day R, Cullinan WE, Chretien M, Seidah NG, Watson SJ. Gene expression of prohormone and proprotein convertases in the rat CNS: a comparative in situ hybridization analysis. J Neurosci. 1993;13(3): 1258-1279
25. Scopsi L, Gullo M, Rilke F, Martin S, Steiner DF. Proprotein convertases (PC1/PC3 and PC2) in normal and neoplastic human tissues: their use as markers of neuroendocrine differentiation. J Clin Endocrinol Metab. 1995;80(1):294-301
26. Day R, Schafer MK, Watson SJ, Chretien M, Seidah NG. Distribution and regulation of the prohormone converta ses PC1 and PC2 in the rat pituitary. Mol Endocrinol. 1992;6(3):485-497
27. Tanaka S, Kurabuchi S, Mochida H, et al. Immunocytochemical localization of prohormone convertases PC1/ PC3 and PC2 in rat pancreatic islets. Arch Histol Cytol. 1996;59(3):261-271
28. Kurabuchi S, Tanaka S. Immunocytochemical localization of prohormone convertases PC1 and PC2 in the mouse thyroid gland and respiratory tract. J Histochem Cytochem. 2002;50(7):903-909
29. Damholt AB, BuchanAM, Holst JJ, Kofod H. Proglucagon processing profile in canine L cells expressing endogenous prohormone convertase 1/3 and prohormone convertase 2. Endocrinology. 1999;140(10):4800-4808
30. Itoh Y, Tanaka S, Takekoshi S, Itoh J, Osamura RY. Prohormone convertases (PC1/3 and PC2) in rat and human pancreas and islet cell tumors: subcellular immunohistochemical analysis. Pathol Int. 1996;46(10):726-737
31. Marcinkiewicz M, Ramla D, Seidah NG, Chretien M. Developmental expression of the prohormone convertases PC1 and PC2 in mouse pancreatic islets. Endocrinology. 1994;135(4):1651-1660
32. Min SY, Kady J, Nam M, et al. Human 'brite/beige' adipocytes develop from capillary networks, and their implantation improves metabolic homeostasis in mice. Nat Med. 2016;22(3):312-318
33. Mbikay M, Sirois F, Yao J, Seidah NG, Chretien M. Comparative analysis of expression of the proprotein convertases furin, PACE4, PC1 and PC2 in human lung tumours. Br J Cancer. 1997;75(10):1509-1514
34. Vindrola O, MayerAM, Citera G, Spitzer JA, Espinoza LR. Prohormone convertases PC2 and PC3 in rat neutrophils and macrophages. Parallel changes with proenkephalinderived peptides induced by LPS in vivo. Neuropeptides. 1994;27(4):235-244
35. LaMendola J, Martin SK, Steiner DF. Expression of PC3, carboxypeptidase E and enkephalin in human monocytederived macrophages as a tool for genetic studies. FEBS Lett. 1997;404(1):19-22
36. Benjannet S, Rondeau N, Day R, Chretien M, Seidah NG. PC1 and PC2 are proprotein convertases capable of cleaving proopiomelanocortin at distinct pairs of basic residues. Proc Natl Acad Sci USA. 1991;88(9):3564-3568
37. Thomas L, Leduc R, Thorne BA, Smeekens SP, Steiner DF, Thomas G. Kex2-like endoproteases PC2 and PC3 accurately cleave a model prohormone in mammalian cells: evidence for a common core of neuroendocrine processing enzymes. Proc Natl Acad Sci USA. 1991;88(12):5297-5301
38. Dhanvantari S, Seidah NG, Brubaker PL. Role of prohormone convertases in the tissue-specific processing of proglucagon. Mol Endocrinol. 1996;10(4):342-355
39. Rouille Y, Kantengwa S, Irminger JC, Halban PA. Role of the prohormone convertase PC3 in the processing of proglucagon to glucagon-like peptide 1. J Biol Chem. 1997; 272(52):32810-32816
40. Zhou A, Mains RE. Endoproteolytic processing of proopiomelanocortin and prohormone convertases 1 and 2 in neuroendocrine cells overexpressing prohormone convertases 1 or 2. J Biol Chem. 1994;269(26):17440-17447
41. Kaufmann JE, Irminger JC, Mungall J, Halban PA. Proinsulin conversion in GH3 cells after coexpression of human proinsulin with the endoproteases PC2 and/or PC3. Diabetes. 1997;46(6):978-982
42. Irminger JC, Meyer K, Halban P. Proinsulin processing in the rat insulinoma cell line INS after overexpression of the endoproteases PC2 or PC3 by recombinant adenovirus. Biochem J. 1996;320:11-15
43. Rouille Y, Bianchi M, Irminger JC, Halban PA. Role of the prohormone convertase PC2 in the processing of proglucagon to glucagon. FEBS Lett. 1997;413:119-123
44. Dhanvantari S, Brubaker PL. Proglucagon processing in an islet cell line: effects of PC1 overexpression and PC2 depletion. Endocrinology. 1998;139(4):1630-1637
45. D'Agostino G, Diano S. β-Melanocyte stimulating hormone: production and degradation. J Mol Med. 2010; 88(12):1195-1201
46. Dillon SL, WilliamsonDM, Elferich J, et al. Propeptides are sufficient to regulate organelle-specific pH-dependent activation of furin and proprotein convertase 1/3. J Mol Biol. 2012;423(1):47-62
47. Bissonnette L, Charest G, Longpre JM, Lavigne P, Leduc R. Identification of furin pro-region determinants involved in folding and activation. Biochem J. 2004;379:757-763
48. Muller L, Lindberg I. The cell biology of the prohormone convertases PC1 and PC2. Prog Nucleic Acid Res Mol Biol. 1999;63:69-108
49. Creemers JW, van de Loo JW, Plets E, Hendershot LM, Van De Ven WJ. Binding of BiP to the processing enzyme lymphoma proprotein convertase prevents aggregation, but slows down maturation. J Biol Chem. 2000;275(49): 38842-38847
50. Zhou A, Paquet L, Mains RE. Structural elements that direct specific processing of different mammalian subtilisinlike prohormone convertases. J Biol Chem. 1995;270(37): 21509-21516
51. Anderson ED, VanSlyke JK, ThulinCD, Jean F, ThomasG. Activation of the furin endoprotease is a multiple-step process: requirements for acidification and internal propeptide cleavage. EMBO J. 1997;16(7):1508-1518
52. Williamson DM, Elferich J, Ramakrishnan P, Thomas G, Shinde U. The mechanism by which a propeptide-encoded pH sensor regulates spatiotemporal activation of furin. J Biol Chem. 2013;288(26):19154-19165
53. Williamson DM, Elferich J, Shinde U. Mechanism of finetuningpHsensors in proprotein convertases: identification of a pH-sensing histidine pair in the propeptide of proprotein convertase 1/3. J Biol Chem. 2015;290(38):23214-23225
54. Rabah N, Gauthier D, Wilkes BC, Gauthier DJ, Lazure C. Single amino acid substitution in the PC1/3 propeptide can induce significant modifications of its inhibitory profile toward its cognate enzyme. J Biol Chem. 2006;281(11): 7556-7567
55. Zhong M, Munzer JS, Basak A, et al. The prosegments of furin and PC7 as potent inhibitors of proprotein convertases. In vitro and ex vivo assessment of their efficacy and selectivity. J Biol Chem. 1999;274(48):33913-33920
56. FugèreM, Limperis PC, Beaulieu-Audy V, et al. Inhibitory potency and specificity of subtilase-like pro-protein condoi vertase (SPC) prodomains. J Biol Chem. 2002;277(10): 7648-7656
57. Lee SN, Prodhomme E, Lindberg I. Prohormone convertase 1 (PC1) processing and sorting: effect of PC1 propeptide and proSAAS. J Endocrinol. 2004;182(2):353-364
58. Anderson ED, Molloy SS, Jean F, Fei H, Shimamura S, Thomas G. The ordered and compartment-specific autoproteolytic removal of the furin intramolecular chaperone is required for enzyme activation. J Biol Chem. 2002; 277(15):12879-12890
59. Tangrea MA, Bryan PN, Sari N, Orban J. Solution structure of the pro-hormone convertase 1 pro-domain from Mus musculus. J Mol Biol. 2002;320(4):801-812
60. Lipkind G, Gong Q, Steiner DF. Molecular modeling of the substrate specificity of prohormone convertases SPC2 and SPC3. J Biol Chem. 1995;270(22):13277-13284
61. Creemers JW, Siezen RJ, Roebroek AJ, Ayoubi TA, Huylebroeck D, Van de Ven WJ. Modulation of furin-mediated proprotein processing activity by site-directed mutagenesis. J Biol Chem. 1993;268(29):21826-21834
62. Henrich S, Cameron A, Bourenkov GP, et al. The crystal structure of the proprotein processing proteinase furin explains its stringent specificity. Nat Struct Biol. 2003;10(7): 520-526
63. Henrich S, Lindberg I, Bode W, Than ME. Proprotein convertase models based on the crystal structures of furin and kexin: explanation of their specificity. J Mol Biol. 2005; 345(2):211-227
64. Dahms SO, Hardes K, Becker GL, Steinmetzer T, Brandstetter H, Than ME. X-ray structures of human furin in complex with competitive inhibitors. ACS Chem Biol. 2014;9(5):1113-1118
65. Ueda K, Lipkind GM, Zhou A, et al. Mutational analysis of predicted interactions between the catalytic and P domains of prohormone convertase 3 (PC3/PC1). Proc Natl Acad Sci USA. 2003;100(10):5622-5627
66. Lusson J, Benjannet S, Hamelin J, Savaria D, Chretien M, Seidah NG. The integrity of the RRGDL sequence of the proprotein convertase PC1 is critical for its zymogen and C-terminal processing and for its cellular trafficking. Biochem J. 1997;326:737-744
67. RovèreC, Luis J, Lissitzky JC, et al. TheRGDmotif and the C-terminal segment of proprotein convertase 1 are critical for its cellular trafficking but not for its intracellular binding to integrin β5α1. J Biol Chem. 1999;274(18):12461-12467
68. Dikeakos JD, Di Lello P, LacombeMJ, et al. Functional and structural characterization of a dense core secretory granule sorting domain from the PC1/3 protease. Proc Natl Acad Sci USA. 2009;106(18):7408-7413
69. Jutras I, Seidah NG, Reudelhuber TL. A predicted β-helix mediates targeting of the proprotein convertase PC1 to the regulated secretory pathway. J Biol Chem. 2000;275(51): 40337-40343
70. Dikeakos JD, Mercure C, Lacombe MJ, Seidah NG, Reudelhuber TL. PC1/3, PC2 and PC5/6A are targeted to dense core secretory granules by a common mechanism. FEBS J. 2007;274(16):4094-4102
71. Benjannet S, Rondeau N, Paquet L, et al. Comparative biosynthesis, covalent post-translational modifications and efficiency of prosegment cleavage of the prohormone convertases PC1 and PC2: glycosylation, sulphation and identification of the intracellular site of prosegment cleavage of PC1 and PC2. Biochem J. 1993;294:735-743
72. Zandberg WF, Benjannet S, Hamelin J, Pinto BM, Seidah NG. N-Glycosylation controls trafficking, zymogen activation and substrate processing of proprotein convertases PC1/3 and subtilisin kexin isozyme-1. Glycobiology. 2011;21(10):1290-1300
73. Creemers JW, Choquet H, Stijnen P, et al. Heterozygous mutations causing partial prohormone convertase 1 deficiency contribute to human obesity. Diabetes 2012;61(2): 383-390
74. Lindberg I. Evidence for cleavage of the PC1/PC3 pro-segment in the endoplasmic reticulum. Mol Cell Neurosci. 1994;5(3):263-268
75. Hoshino A, Kowalska D, Jean F, Lazure C, Lindberg I. Modulation of PC1/3 activity by self-interaction and substrate binding. Endocrinology. 2011;152(4):1402-1411
76. Zhou Y, Lindberg I. Enzymatic properties of carboxylterminally truncated prohormone convertase 1 (PC1/ SPC3) and evidence for autocatalytic conversion. J Biol Chem. 1994;269(28):18408-18413
77. Rufaut NW, Brennan SO, Hakes DJ, Dixon JE, Birch NP. Purification and characterization of the candidate prohormone-processing enzyme SPC3 produced in a mouse L cell line. J Biol Chem. 1993;268(27):20291-20298
78. Boudreault A, Gauthier D, Rondeau N, et al. Molecular characterization, enzymatic analysis, and purification of murine proprotein convertase-1/3 (PC1/PC3) secreted from recombinant baculovirus-infected insect cells. Protein Expr Purif. 1998;14(3):353-366
79. Milgram SL, Mains RE. Differential effects of temperature blockade on the proteolytic processing of three secretory granule-associated proteins. J Cell Sci. 1994;107:737-745
80. Villeneuve P, Feliciangeli S, Croissandeau G, et al. Altered processing of the neurotensin/neuromedin N precursor in PC2 knock down mice: a biochemical and immunohistochemical study. J Neurochem. 2002;82(4):783-793
81. Wardman JH, Zhang X, Gagnon S, et al. Analysis of peptides in prohormone convertase 1/3 null mouse brain using quantitative peptidomics. J Neurochem. 2010;114(1): 215-225
82. O'Rahilly S, Gray H, Humphreys PJ, et al. Brief report: impaired processing of prohormones associated with abnormalities of glucose homeostasis and adrenal function. N Engl J Med. 1995;333(21):1386-1390
83. Jackson RS, Creemers JW, Ohagi S, et al. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet. 1997;16(3):303-306
84. Goodge KA, Hutton JC. Translational regulation of proinsulin biosynthesis and proinsulin conversion in the pancreatic α-cell. Semin Cell Dev Biol. 2000;11(4):235-242
85. Jackson RS, Creemers JW, Farooqi IS, et al. Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. J Clin Invest. 2003;112(10):1550-1560
86. Farooqi IS, Volders K, Stanhope R, et al. Hyperphagia and early-onset obesity due to a novel homozygous missense mutation in prohormone convertase 1/3. J Clin Endocrinol Metab. 2007;92(9):3369-3373
87. Frank GR, Fox J, Candela N, et al. Severe obesity and diabetes insipidus in a patient with PCSK1 deficiency. Mol Genet Metab. 2013;110:191-194
88. Martín MG, Lindberg I, Solorzano-Vargas RS, et al. Congenital proprotein convertase 1/3 deficiency causes malabsorptive diarrhea and other endocrinopathies in a pediatric cohort. Gastroenterology. 2013;145(1):138-148
89. BlancoEH, Ramos-Molina B, Lindberg I. Revisiting PC1/3 mutants: dominant-negative effect of endoplasmic reticulum-retained mutants. Endocrinology. 2015;156(10): 3625-3637
90. Yourshaw M, Solorzano-Vargas RS, Pickett LA, et al. Exome sequencing finds a novel PCSK1 mutation in a child with generalized malabsorptive diarrhea and diabetes insipidus. J Pediatr Gastroenterol Nutr. 2013;57(6):759-767
91. Bandsma RH, Sokollik C, Chami R, et al. From diarrhea to obesity in prohormone convertase 1/3 deficiency: age-dependent clinical, pathologic, and enteroendocrine characteristics. J Clin Gastroenterol. 2013;47(10):834-843
92. Wilschanski M, Abbasi M, Blanco E, et al.Anovel familial mutation in the PCSK1 gene that alters the oxyanion hole residue of proprotein convertase 1/3 and impairs its enzymatic activity. PLoS One. 2014;9(10):e108878
93. Härter B, Fuchs I, Müller T, Akbulut UE, CakirM, Janecke AR. Early clinical diagnosis of PC1/3 deficiency in a patient with a novel homozygousPCSK1splice-site mutation. J Pediatr Gastroenterol Nutr. 2016;62(4):577-580
94. Wang J, Cortina G, Wu SV, et al. Mutant neurogenin-3 in congenital malabsorptive diarrhea. N Engl J Med. 2006; 355(3):270-280
95. Nead KT, Li A, Wehner MR, et al. Contribution of common non-synonymous variants in PCSK1 to body mass index variation and risk of obesity: a systematic review and meta-analysis with evidence from up to 331 175 individuals. Hum Mol Genet. 2015;24(12):3582-3594
96. Philippe J, Stijnen P, Meyre D, et al. A nonsense loss-offunction mutation in PCSK1 contributes to dominantly inherited human obesity. Int J Obes (Lond). 2015;39(2): 295-302
97. Benzinou M, Creemers JW, Choquet H, et al. Common nonsynonymous variants in PCSK1 confer risk of obesity. Nat Genet. 2008;40(8):943-945
98. Mbikay M, Sirois F, Nkongolo KK, Basak A, Chretien M. Effects of rs6234/rs6235 and rs6232/rs6234/rs6235 PCSK1 single-nucleotide polymorphism clusters on proprotein convertase 1/3 biosynthesis and activity. Mol Genet Metab. 2011;104(4):682-687
99. Chang YC, Chiu YF, Shih KC, et al. Common PCSK1 haplotypes are associated with obesity in the Chinese population. Obesity (Silver Spring). 2010;18(7):1404-1409
100. Kilpeläinen TO, Bingham SA, Khaw KT, Wareham NJ, Loos RJ. Association of variants in the PCSK1 gene with obesity in the EPIC-Norfolk study.HumMol Genet. 2009; 18(18):3496-3501
101. Qi Q, Li H, Loos RJ, et al. Association of PCSK1 rs6234 with obesity and related traits in a Chinese Han population. PLoS One. 2010;5(5):e10590
102. Renström F, Payne F, Nordström A, et al. Replication and extension of genome-wide association study results for obesity in 4923 adults from northern Sweden. Hum Mol Genet. 2009;18(8):1489-1496
103. Rouskas K, Kouvatsi A, Paletas K, et al. Common variants in FTO, MC4R, TMEM18, PRL, AIF1, and PCSK1 show evidence of association with adult obesity in the Greek population. Obesity (Silver Spring). 2012;20(2):389-395
104. Sandholt CH, Sparsø T, Grarup N, et al. Combined analyses of 20 common obesity susceptibility variants. Diabetes. 2010;59(7):1667-1673
105. Choquet H, Kasberger J, Hamidovic A, Jorgenson E. Contribution of common PCSK1 genetic variants to obesity in 8, 359 subjects from multi-ethnic American population. PLoS One. 2013;8(2):e57857
106. Villalobos-Comparan M, Villamil-Ramírez H, Villarreal-Molina T, et al. PCSK1 rs6232 is associated with childhood and adult class III obesity in the Mexican population. PLoS One. 2012;7(6):e39037
107. Heni M, Haupt A, Schäfer SA, et al. Association of obesity risk SNPs in PCSK1 with insulin sensitivity and proinsulin conversion. BMC Med Genet. 2010;11:86
108. Gjesing AP, Vestmar MA, Jørgensen T, et al. The effect of PCSK1 variants on waist, waist-hip ratio and glucose metabolism is modified by sex and glucose tolerance status. PLoS One. 2011;6(9):e23907
109. Willer CJ, Speliotes EK, Loos RJ, et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet. 2009;41(1):25-34
110. Heid IM, Jackson AU, Randall JC, et al. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet. 2010;42(11):949-960
111. Strawbridge RJ, Dupuis J, Prokopenko I, et al. Genomewide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes. 2011;60(10):2624-2634
112. Li XM, Ling Y, Lu DR, et al. The obesity-related polymorphism PCSK1 rs6235 is associated with essential hypertension in the Han Chinese population. Hypertens Res. 2012;35(10):994-999
113. Stijnen P, Tuand K, Varga TV, Franks PW, Aertgeerts B, Creemers JW. The association of common variants in PCSK1 with obesity: a HuGE review and meta-analysis. Am J Epidemiol. 2014;180(11):1051-1065
114. Pickett LA, Yourshaw M, Albornoz V, et al. Functional consequences of a novel variant of PCSK1. PLoS One. 2013;8(1):e55065
115. Wen W, Cho YS, Zheng W, et al. Meta-analysis identifies common variants associated with body mass index in east Asians. Nat Genet. 2012;44(3):307-311
116. Liu CT, Monda KL, Taylor KC, et al. Genome-wide association of body fat distribution in African ancestry populations suggests new loci. PLoS Genet. 2013;9(8): e1003681
117. Fontanesi L, Bertolini F, Scotti E, et al. Polymorphisms in an obesity-related gene (PCSK1) are associated with fat deposition and production traits in Italian heavy pigs. Animal. 2012;6(12):1913-1924
118. Zhang H, HuX, Wang Z, et al. Selection signature analysis implicates the PC1/PCSK1 region for chicken abdominal fat content. PLoS One. 2012;7(7):e40736
119. Shan L, Sun J, Zhang C, et al. The polymorphisms of bovine PCSK1 gene and their associations with growth traits. Genes Genom. 2011;33(1):57-63
120. Sun J, Zhang C, Fang X, Lei C, Lan X, Chen H. Novel single nucleotide polymorphisms of the caprine PC1 gene and association with growth traits. Biochem Genet. 2010; 48:779-788
121. Kimchi-Sarfaty C, Oh JM, Kim IW, et al. A "silent" polymorphism in theMDR1gene changes substrate specificity. Science. 2007;315(5811):525-528
122. Stefanovic B, Hellerbrand C, Brenner DA. Regulatory role of the conserved stem-loop structure at the 5β end of collagen β1(I) mRNA. Mol Cell Biol. 1999;19(6):4334-4342
123. Creemers JW, Pritchard LE, Gyte A, et al. Agouti-related protein is posttranslationally cleaved by proprotein convertase 1 to generate agouti-related protein (AGRP)83-132: interaction between AGRP83-132 and melanocortin receptors cannot be influenced by syndecan-3. Endocrinology. 2006;147(4):1621-1631
124. Laurent V, Jaubert-Miazza L, Desjardins R, Day R, Lindberg I. Biosynthesis of proopiomelanocortin-derived peptides in prohormone convertase 2 and 7B2 null mice. Endocrinology. 2004;145(2):519-528
125. Bell ME, McDonald TJ, Myers DA. Proopiomelanocortin processing in the anterior pituitary of the ovine fetus after lesion of the hypothalamic paraventricular nucleus. Endocrinology. 2005;146(6):2665-2673
126. Broberger C, Johansen J, Johansson C, Schalling M, Hökfelt T. The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc Natl Acad Sci USA. 1998;95(25):15043-15048
127. Jeong JK, KimJG, Lee BJ. Participation of the central melanocortin system in metabolic regulation and energy homeostasis. Cell Mol Life Sci. 2014;71(19):3799-3809
128. Crowley VE. Overview of human obesity and central mechanisms regulating energy homeostasis. Ann Clin Biochem. 2008;45:245-255
129. Zheng H, Patterson LM, Phifer CB, Berthoud HR. Brain stem melanocortinergic modulation of meal size and identification of hypothalamic POMC projections. Am J Physiol Regul Integr Comp Physiol. 2005;289(1):R247-R258
130. Challis BG, Pritchard LE, Creemers JW. A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism. Hum Mol Genet. 2002;11(17):1997-2004
131. Challis BG, Millington GW. Proopiomelanocortin Deficiency. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Fong CT, Mefford HC, Smith RJH, Stephens K, editors. SourceGeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2016
132. Yaswen L, Diehl N, Brennan MB, Hochgeschwender U. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med. 1999;5(9):1066-1070
133. Luquet S, Perez FA, Hnasko TS, Palmiter RD. NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science. 2005;310(5748):683-685
134. Qian S, Chen H, Weingarth D, et al. Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Mol Cell Biol. 2002;22(14):5027-5035
135. Paquet L, Zhou A, Chang EY, Mains RE. Peptide biosynthetic processing: distinguishing prohormone convertases PC1 and PC2. Mol Cell Endocrinol. 1996;120(2):161-168
136. Miller R, Toneff T, Vishnuvardhan D, Beinfeld M, Hook VY. Selective roles for the PC2 processing enzyme in the regulation of peptide neurotransmitter levels in brain and peripheral neuroendocrine tissues of PC2 deficient mice. Neuropeptides. 2003;37(3):140-148
137. Paquet L, Massie B, Mains RE. Proneuropeptide Y processing in large dense-core vesicles: manipulation of prohormone convertase expression in sympathetic neurons using adenoviruses. J Neurosci. 1996;16:964-973
138. Brakch N, Rist B, Beck-Sickinger AG, et al. Role of prohormone convertases in pro-neuropeptide Y processing: coexpression and in vitro kinetic investigations. Biochemistry. 1997;36(51):16309-16320
139. Gagnon J, Mayne J, Chen A, et al. PCSK2-null mice exhibit delayed intestinal motility, reduced refeeding response and altered plasma levels of several regulatory peptides. Life Sci. 2011;88:212-217
140. Larhammar D, Salaneck E. Molecular evolution of NPY receptor subtypes. Neuropeptides. 2004;38(4):141-151
141. Stein J, Steiner DF, Dey A. Processing of cocaine-and amphetamine-regulated transcript (CART) precursor proteins by prohormone convertases (PCs) and its implications. Peptides. 2006;27(8):1919-1925
142. Kristensen P, Judge ME, Thim L, et al. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature. 1998;393(6680):72-76
143. Wierup N, Richards WG, Bannon AW, Kuhar MJ, Ahren B, Sundler F. CART knock out mice have impaired insulin secretion and glucose intolerance, altered α cell morphology and increased body weight. Regul Pept. 2005;129: 203-211
144. Marcinkiewicz M, Savaria D, Marcinkiewicz J. The proprotein convertase PC1 is induced in the transected sciatic nerve and is present in cultured Schwann cells: comparison with PC5, furin and PC7, implication in pro-BDNF processing. Brain Res Mol Brain Res. 1998;59(2):229-246
145. Lebrun B, Bariohay B, Moyse E, Jean A. Brain-derived neurotrophic factor (BDNF) and food intake regulation: a minireview. Auton Neurosci. 2006;126-127:30-38
146. Gray J, Yeo GS, Cox JJ, et al. Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes. 2006;55(12): 3366-3371
147. Wetsel WC, Rodriguiz RM, Guillemot J, et al. Disruption of the expression of the proprotein convertase PC7 reduces BDNF production and affects learning and memory in mice. Proc Natl Acad Sci USA. 2013;110(43):17362-17367
148. Zhu X, Zhou A, Dey A, et al. Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects. Proc Natl Acad Sci USA. 2002; 99(16):10293-10298
149. Gorski JA, Balogh SA, Wehner JM, Jones KR. Learning deficits in forebrain-restricted brain-derived neurotrophic factor mutant mice. Neuroscience. 2003;121(2):341-354
150. Nilaweera KN, Barrett P, Mercer JG, Morgan PJ. Precursor-protein convertase 1 gene expression in the mouse hypothalamus: differential regulation by ob gene mutation, energy deficit and administration of leptin, and coexpression with prepro-orexin. Neuroscience. 2003;119(3):713-720
151. Viale A, Ortola C, Hervieu G, et al. Cellular localization and role of prohormone convertases in the processing of pro-melanin concentrating hormone in mammals. J Biol Chem. 1999;274(10):6536-6545
152. Shimada M, Tritos NA, Lowell BB, Flier JS, Maratos-Flier E. Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature. 1998;396(6712):670-674
153. Baird JP, Choe A, Loveland JL, et al. Orexin-A hyperphagia: hindbrain participation in consummatory feeding responses. Endocrinology. 2009;150(3):1202-1216
154. Coates LC, Birch NP. Differential cleavage of provasopressin by the major molecular forms of SPC3. J Neurochem. 1998;70(4):1670-1678
155. Hardiman A, Friedman TC, Grunwald WC, et al. Endocrinomic profile of neurointermediate lobe pituitary prohormone processing in PC1/3-and PC2-null mice using SELDI-TOF mass spectrometry. J Mol Endocrinol. 2005; 34(3):739-751
156. Gould BR, Zingg HH. Mapping oxytocin receptor gene expression in the mouse brain and mammary gland using an oxytocin receptor-LacZ reporter mouse. Neuroscience. 2003;122(1):155-167
157. Ozawa A, Cai Y, Lindberg I. Production of bioactive peptides in an in vitro system. Anal Biochem. 2007;366:182-189
158. Zhu X, Cao Y, Voogd K, Voodg K, Steiner DF. On the processing of proghrelin to ghrelin. J Biol Chem. 2006; 281(50):38867-38870
159. CowleyMA, SmithRG, Diano S, et al.The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron. 2003;37(4):649-661
160. Zhang J, Liu S, Tang M, Chen JD. Optimal locations and parameters of gastric electrical stimulation in altering ghrelin and oxytocin in the hypothalamus of rats. Neurosci Res. 2008;62(4):262-269
161. van der Plasse G, MerkesteinM, LuijendijkMC, et al. Food cues and ghrelin recruit the same neuronal circuitry. Int J Obes (Lond). 2013;37(7):1012-1019
162. Rehfeld JF, Lindberg I, Friis-Hansen L. Increased synthesis but decreased processing of neuronal proCCK in prohormone convertase 2 and 7B2 knockout animals. J Neurochem. 2002;83:1329-1337
163. Wang W, Birch NP, Beinfeld MC. Prohormone convertase 1 (PC1) when expressed with pro cholecystokinin (pro CCK) in L cells performs three endoproteolytic cleavages which are observed in rat brain and in CCK-expressing endocrine cells in culture, including the production of glycine and arginine extended CCK8. Biochem Biophys Res Commun. 1998;248(3):538-541
164. Wang W, Beinfeld MC. Cleavage of CCK 33 by recombinant PC2 in vitro. Biochem Biophys Res Commun. 1997; 231(1):149-152
165. Vishnuvardhan D, Connolly K, Cain B, Beinfeld MC. PC2 and 7B2 null mice demonstrate that PC2 is essential for normal pro-CCK processing. Biochem Biophys Res Commun. 2000;273:188-191
166. Tagen MB, Beinfeld MC. Recombinant prohormone convertase 1 and 2 cleave purified pro cholecystokinin (CCK) and a synthetic peptide containingCCK8 Gly Arg Arg and the carboxyl-terminal flanking peptide. Peptides. 2005; 26(12):2530-2535
167. Smith GP. Cholecystokinin and treatment of meal size: proof of principle. Obesity (Silver Spring). 2006;14(suppl 4):168S-170S
168. Barrera JG, Sandoval DA, D'Alessio DA, Seeley RJ. GLP-1 and energy balance: an integrated model of short-term and long-term control. Nat Rev Endocrinol. 2011;7(9):507-516
169. Bailyes EM, Shennan KI, Seal AJ, et al. A member of the eukaryotic subtilisin family (PC3) has the enzymic properties of the type 1 proinsulin-converting endopeptidase. Biochem J. 1992;285:391-394
170. Bailyes EM, Shennan KI, Usac EF, et al. Differences between the catalytic properties of recombinant human PC2 and endogenous rat PC2. Biochem J. 1995;309:587-594
171. FurutaM, Carroll R, Martin S, et al. Incomplete processing of proinsulin to insulin accompanied by elevation of Des-31, 32 proinsulin intermediates in islets of mice lacking active PC2. J Biol Chem. 1998;273(6):3431-3437
172. Zhu X, Orci L, Carroll R, Norrbom C, Ravazzola M, Steiner DF. Severe block in processing of proinsulin to insulin accompanied by elevation of des-64, 65 proinsulin intermediates in islets of mice lacking prohormone convertase 1/3. Proc Natl Acad SciUSA. 2002;99(16):10299-10304
173. Liu M, Hodish I, Rhodes CJ, Arvan P. Proinsulin maturation, misfolding, and proteotoxicity. Proc Natl Acad Sci USA. 2007;104(40):15841-15846
174. Obici S, Zhang BB, Karkanias G, Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med. 2002;8(12):1376-1382
175. Milanski M, Arruda AP, Coope A, et al. Inhibition of hypothalamic inflammation reverses diet-induced insulin resistance in the liver. Diabetes. 2012;61(6):1455-1462
176. Hill JW, Elias CF, FukudaM, et al. Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertility. Cell Metab. 2010;11(4):286-297
177. Gagnon J, Mayne J, Mbikay M, Woulfe J, Chretien M. Expression of PCSK1 (PC1/3), PCSK2 (PC2) and PCSK3 (furin) in mouse small intestine. Regul Pept. 2009;152: 54-60
178. Ugleholdt R, Poulsen ML, Holst PJ, et al. Prohormone convertase 1/3 is essential for processing of the glucosedependent insulinotropic polypeptide precursor. J Biol Chem. 2006;281(16):11050-11057
179. Rehfeld JF, Zhu X, Norrbom C, et al. Prohormone convertases 1/3 and 2 together orchestrate the site-specific cleavages of progastrin to release gastrin-34 and gastrin-17 Biochem J. 2008;415(1):35-43
180. Sawada M, Finniss S, Dickinson CJ. Diminished prohormone convertase 3 expression (PC1/PC3) inhibits progastrin post-translational processing. Regul Pept. 2000;89: 19-28
181. Dickinson CJ, Sawada M, Guo YJ, Finniss S, Yamada T. Specificity of prohormone convertase endoproteolysis of progastrin in AtT-20 cells. J Clin Invest. 1995;96:1425-1431
182. Rehfeld JF. The endoproteolytic maturation of progastrin and procholecystokinin. J Mol Med (Berl). 2006;84(7): 544-550
183. Wetsel WC, Liposits Z, Seidah NG, Collins S. Expression of candidate pro-GnRH processing enzymes in rat hypothalamus and an immortalized hypothalamic neuronal cell line. Neuroendocrinology. 1995;62(2):166-177
184. Harihar S, Pounds KM, Iwakuma T, Seidah NG, Welch DR. Furin is the major proprotein convertase required for KISS1-to-Kisspeptin processing. PLoS One. 2014;9(1): e84958
185. Nillni EA, Friedman TC, Todd RB, Birch NP, Loh YP, Jackson IM. Pro-thyrotropin-releasing hormone processing by recombinant PC1. J Neurochem. 1995;65(6):2462-2472
186. Friedman TC, Loh YP, Cawley NX, et al. Processing of prothyrotropin-releasing hormone (Pro-TRH) by bovine intermediate lobe secretory vesicle membrane PC1 and PC2 enzymes. Endocrinology. 1995;136(10):4462-4472
187. Cyr NE, Stuart RC, Zhu X, Steiner DF, Nillni EA. Biosynthesis of proTRH-derived peptides in prohormone convertase 1 and 2 knockout mice. Peptides. 2012;35(1):42-48
188. Fukuda Y, Kageyama K, Nigawara T, Kasagi Y, Suda T. Effects of corticotropin-releasing hormone (CRH) on the synthesis and secretion of proopiomelanocortin-related peptides in the anterior pituitary: a study using CRH-deficient mice. Neurosci Lett. 2004;367(2):201-204
189. Brar B, Sanderson T, Wang N, Lowry PJ. Post-translational processing of human procorticotrophin-releasing factor in transfected mouse neuroblastoma and Chinese hamster ovary cell lines. J Endocrinol. 1997;154:431-440
190. Posner SF, Vaslet CA, JurofcikM, Lee A, SeidahNG, Nillni EA. Stepwise posttranslational processing of progrowth hormone-releasing hormone (proGHRH) polypeptide by furin and PC1. Endocrine. 2004;23:199-213
191. Dey A, Norrbom C, Zhu X, et al. Furin and prohormone convertase 1/3 are major convertases in the processing of mouse pro-growth hormone-releasing hormone. Endocrinology. 2004;145(4):1961-1971
192. Zhang X, Pan H, Peng B, Steiner DF, Pintar JE, Fricker LD. Neuropeptidomic analysis establishes a major role for prohormone convertase-2 in neuropeptide biosynthesis. J Neurochem. 2010;112:1168-1179
193. Pan H, Nanno D, Che FY, et al. Neuropeptide processing profile in mice lacking prohormone convertase-1. Biochemistry. 2005;44(12):4939-4948
194. Creemers JW, Jackson RS, Hutton JC. Molecular and cellular regulation of prohormone processing. Semin CellDev Biol. 1998;9(1):3-10
195. Thomas PD, Forbes A, Green J, et al. Guidelines for the investigation of chronic diarrhoea, 2nd edition. Gut. 2003; 52(suppl 5):v1-v15
196. Passariello A, Terrin G, Baldassarre ME, De Curtis M, Paludetto R, Berni Canani R. Diarrhea in neonatal intensive care unit. World J Gastroenterol. 2010;16(21):2664-2668
197. Canani RB, Castaldo G, Bacchetta R, Martín MG, Goulet O. Congenital diarrhoeal disorders: advances in this evolving web of inherited enteropathies. Nat Rev Gastroenterol Hepatol. 2015;12(5):293-302
198. Jeppesen PB, Sanguinetti EL, Buchman A, et al. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut. 2005;54(9): 1224-1231
199. Patel D. Pharmacotherapy for the management of obesity. Metabolism. 2015;64(11):1376-1385
200. Apovian CM, Aronne LJ, Bessesen DH, et al. Pharmacological management of obesity: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015; 100(2):342-362
201. Sheng M, Hosseinzadeh A, Muralidharan SV, Gaur R, Selstam E, Tuck S. Aberrant fat metabolism in Caenorhabditis elegans mutants with defects in the defecation motor program. PLoS One 2015;10(4):e0124515
202. Refaie S, Gagnon S, Gagnon H, et al. Disruption of proprotein convertase 1/3 (PC1/3) expression in mice causes innate immune defects and uncontrolled cytokine secretion. J Biol Chem. 2012;287(18):14703-14717
203. Mbikay M, Croissandeau G, Sirois F, et al. A targeted deletion/insertion in the mouse Pcsk1 locus is associated with homozygous embryo preimplantation lethality, mutant allele preferential transmission and heterozygous female susceptibility to dietary fat. Dev Biol. 2007;306(2): 584-598
204. Lloyd DJ, Bohan S, Gekakis N. Obesity, hyperphagia and increased metabolic efficiency in Pc1 mutant mice. Hum Mol Genet. 2006;15(11):1884-1893
205. Stijnen P, Brouwers B, Dirkx E, et al. Endoplasmic reticulum-associated degradation of the mouse PC1/3-N222D hypomorph and human PCSK1 mutations contributes to obesity. Int J Obes. 2016;40(6):973-981
206. Prabhu Y, Blanco EH, Liu M, et al. Defective transport of the obesity mutant PC1/3 N222D contributes to loss of function. Endocrinology. 2014;155(7):2391-2401
207. Strausberg SL, Alexander PA, Gallagher DT, Gilliland GL, Barnett BL, Bryan PN. Directed evolution of a subtilisin with calcium-independent stability. Biotechnology (N Y). 1995;13(7):669-673
208. Geva Y, Schuldiner M. The back and forth of cargo exit from the endoplasmic reticulum. Curr Biol. 2014;24(3): R130-R136
209. Izumi T, Yokota-Hashimoto H, Zhao S, Wang J, Halban PA, Takeuchi T. Dominant negative pathogenesis by mutant proinsulin in the Akita diabetic mouse. Diabetes. 2003;52(2):409-416
210. Ozcan L, Ergin AS, Lu A, et al. Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab. 2009;9(1):35-51
211. Back SH, Kaufman RJ. Endoplasmic reticulum stress and type 2 diabetes. Annu Rev Biochem. 2012;81:767-793
212. Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013;8(11):2281-2308
213. Duckert P, Brunak S, Blom N. Prediction of proprotein convertase cleavage sites. Protein Eng Des Sel. 2004;17(1): 107-112
214. Southey BR, Amare A, Zimmerman TA, Rodriguez-Zas SL, Sweedler JV. NeuroPred: a tool to predict cleavage sites in neuropeptide precursors and provide the masses of the resulting peptides. Nucleic Acids Res. 2006;34(Web Server issue):W267-W272
215. ZhangF, Lupski JR. Non-coding genetic variants inhuman disease. Hum Mol Genet. 2015;24(R1):R102-R110
216. Fernandez-Escamilla AM, Rousseau F, Schymkowitz J, Serrano L. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat Biotechnol. 2004;22(10):1302-1306
217. Maurer-Stroh S, Debulpaep M, Kuemmerer N, et al. Exploring the sequence determinants of amyloid structure using position-specific scoring matrices. Nat Methods. 2010;7(3):237-242
218. Schymkowitz J, Borg J, Stricher F, Nys R, Rousseau F, Serrano L. The FoldX web server: an online force field. Nucleic Acids Res. 2005;33(Web Server issue):W382-W388